Growth Metrics

Bluejay Diagnostics (BJDX) Notes Payables (2020 - 2024)

Bluejay Diagnostics recorded quarterly Notes Payables of $147440.0 in Q2 2024, up 1374.4% quarter-over-quarter from $10000.0 in Q4 2021.

Bluejay Diagnostics' Notes Payables history runs 3 years deep, the most recent figure standing at $147440.0 for Q2 2024.

  • In Q2 2024, Notes Payables changed N/A year-over-year to $147440.0; the TTM figure through Jun 2024 stood at $147440.0 (changed N/A YoY), while the FY2021 annual figure was $10000.0, down 32.09% from the prior year.
  • Notes Payables came in at $147440.0 for Q2 2024 at Bluejay Diagnostics, up from $10000.0 in the prior quarter.
  • In the past five years, Notes Payables ranged from a high of $147440.0 in Q2 2024 to a low of $10000.0 in Q3 2021.
  • A 3-year average of $45541.2 and a median of $12362.5 in 2020 frame the typical range for Notes Payables.
  • On a YoY basis, Notes Payables climbed as much as 32.09% in 2021 and fell as far as 32.09% in 2021.
  • Bluejay Diagnostics' Notes Payables stood at $14725.0 in 2020, then sank by 32.09% to $10000.0 in 2021, then jumped by 1374.4% to $147440.0 in 2024.
  • According to Business Quant data, Notes Payables over the past three periods registered $147440.0, $10000.0, and $10000.0 for Q2 2024, Q4 2021, and Q3 2021 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn
10 Bluejay Diagnostics 572,394.44 -3.11 Mn -

Historic Data

Download Data 🔒
DateValue
Jun 30, 2024 147,440.00
Dec 31, 2021 10,000.00
Sep 30, 2021 10,000.00
Dec 31, 2020 14,725.00